Subspecialties

Could α-melanocyte–stimulating hormone offer a viable alternative to corneal transplants?

Rahul Tonk is a cornea, cataract and refractive surgeon at the Bascom Palmer Eye Institute in Miami, Florida, USA

A wish-list for the “non-linear” treatment of dry eye disease

Why the Spaeth Richman Contrast Sensitivity test is set to raise the standard of CS assessments

Realizing the potential of precision glaucoma therapy means understanding the foundational pillars of personalized medicine

Iveric Bio’s Erin Henry talks about the potential for the recently-FDA approved Izervay to address unmet needs in geographic atrophy patients

Nicole Fram discusses whether the future of ophthalmology will ever be drop-free

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Fighting gender inequality in ophthalmology and eye care